Flerie AB (publ) (STO:FLERIE)
Sweden · Delayed Price · Currency is SEK 15.00
-0.10 (-0.66%)
Oct 13, 2026, 11:24 AM CET
Flerie AB Market Cap
Flerie AB has a market cap or net worth of 1.3 billion as of October 12, 2026. It is the 23,577th most valuable company in the world and the 293rd biggest in Sweden. Its market cap has decreased by 58.49% in one year.
Market Cap
1.30B
Enterprise Value
996.47M
Revenue
-5.60M
Global Rank
Country Rank
#293 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 2024, Flerie AB's market cap has decreased from 4.11B to 1.30B, a decrease of -68.33%. That is a compound annual growth rate of -38.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 1.30B | -55.17% |
| Dec 30, 2025 | 2.90B | -20.86% |
| Dec 30, 2024 | 3.67B | -10.74% |
| Jun 11, 2024 | 4.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vicore Pharma Holding AB | 2.53B |
| BioInvent International AB | 1.53B |
| Genovis AB (publ.) | 1.37B |
| Saniona AB | 1.32B |
| Oncopeptides AB | 1.17B |
| Infant Bacterial Therapeutics AB | 975.33M |
| SynAct Pharma AB | 946.37M |
| Medivir AB | 932.31M |